NDC 61703-015 – Paclitaxel

Paclitaxel 6 mg/mL · Injection, Solution · Intravenous

Human Prescription Drug 1 recall

Product NDC61703-015

Product details

Brand name
Paclitaxel
Generic name
Paclitaxel
Labeler
Hospira, Inc.
Dosage form
Injection, Solution
Route
Intravenous
Marketing category
ANDA · ANDA076131
Marketed since
April 8, 2025
Listing expires
December 31, 2027
Pharmacologic class
Microtubule Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Paclitaxel →

Package NDC codes (1)

Package NDCDescriptionSince
61703-015-041 VIAL, MULTI-DOSE in 1 CARTON (61703-015-04) / 5 mL in 1 VIAL, MULTI-DOSEApr 8, 2025

Recalls mentioning this NDC

Other Paclitaxel products